Skip to main content
Feedback to SSRN
Feedback
(required)
Email
(required)
Submit
UNITAID IMPAACT4TB Research Group
Independent
Learn more about SSRN Profiles
SCHOLARLY PAPERS
1
DOWNLOADS
93
TOTAL CITATIONS
0
Feedback
Scholarly Papers (1)
Sort by:
Paper Title, A-Z
Paper Title, Z-A
Author Name, A-Z
Author Name, Z-A
Date Posted, Ascending
Date Posted, Descending
Downloads, Ascending
Downloads, Descending
Citations, Ascending
Citations, Descending
Actions:
Email selected abstracts
View:
Selected
Original List
All Versions
Hide All Versions
All Abstracts
Hide All Abstracts
(Rank)
1.
Simultaneous Initiation of Dolutegravir-Based Antiretroviral Treatment and Once-Weekly Rifapentine and Isoniazid (3HP) for Tuberculosis Prevention in Antiretroviral-Naïve People with HIV: A Phase 1/2 Trial
Number of pages: 22
Posted: 12 Sep 2024
Ethel Derby Weld
,
Trevor Beattie
,
Jayajothi Moodley
,
Manasa Mapendere
,
Isadora Salles
,
Belen Perez Solans
,
Bareng A.S. Nonyane
,
Lubbe Wiesner
,
Tanya Nielson
,
Vinodh Edward
,
Violet Chihota
,
Radojka M. Savic
,
Kelly E. Dooley
,
Richard E. Chaisson
,
Gavin Churchyard
,
DOLPHIN-TOO Study Team
and UNITAID IMPAACT4TB Research Group
Johns Hopkins University - Division of Clinical Pharmacology, Aurum Institute, Aurum Institute, Aurum Institute, Johns Hopkins University, University of California, San Francisco (UCSF) - Department of Bioengineering and Therapeutic Sciences, Johns Hopkins University - Bloomberg School of Public Health, University of Cape Town (UCT), Aurum Institute, Aurum Institute, Aurum Institute, University of California, San Francisco (UCSF) - Department of Bioengineering and Therapeutic Sciences, Vanderbilt University - Medical Center, Johns Hopkins University, Aurum Institute, Independent and Independent
Downloads
93
(612,711)
View PDF
Download
Abstract:
Tuberculosis, TB Preventive Treatment, HIV/AIDS, Drug-Drug Interaction Study
Feedback